Cornerstone Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-35,000
| Closed | -$4.3M | – | 130 |
|
|
2025
Q4 | $4.3M | Sell |
35,000
-62,900
| -64% | -$7.64M | 0.14% | 129 |
|
|
2025
Q3 | $10.9M | Sell |
97,900
-1,800
| -2% | -$205K | 0.36% | 72 |
|
|
2025
Q2 | $11.1M | Buy |
99,700
+31,300
| +46% | +$3.33M | 0.38% | 74 |
|
|
2025
Q1 | $7.66M | Hold |
68,400
| – | – | 0.33% | 71 |
|
|
2024
Q4 | $6.32M | Hold |
68,400
| – | – | 0.25% | 94 |
|
|
2024
Q3 | $5.73M | Buy |
68,400
+3,900
| +6% | +$298K | 0.23% | 110 |
|
|
2024
Q2 | $4.43M | Sell |
64,500
-500
| -0.8% | -$33.4K | 0.18% | 124 |
|
|
2024
Q1 | $4.76M | Buy |
65,000
+1,300
| +2% | +$100K | 0.2% | 126 |
|
|
2023
Q4 | $5.16M | Sell |
63,700
-23,500
| -27% | -$1.83M | 0.23% | 113 |
|
|
2023
Q3 | $6.53M | Sell |
87,200
-44,900
| -34% | -$3.45M | 0.3% | 85 |
|
|
2023
Q2 | $10.2M | Sell |
132,100
-32,900
| -20% | -$2.62M | 0.49% | 53 |
|
|
2023
Q1 | $13.7M | Buy |
165,000
+45,000
| +38% | +$3.73M | 0.64% | 45 |
|
|
2022
Q4 | $10.3M | Sell |
120,000
-25,000
| -17% | -$1.98M | 0.51% | 56 |
|
|
2022
Q3 | $8.95M | Buy |
145,000
+25,000
| +21% | +$1.58M | 0.44% | 62 |
|
|
2022
Q2 | $7.42M | Buy |
+120,000
| New | +$7.43M | 0.39% | 73 |
|
|
2021
Q1 | – | Sell |
-94,000
| Closed | -$5.48M | – | 189 |
|
|
2020
Q4 | $5.48M | Hold |
94,000
| – | – | 0.48% | 48 |
|
|
2020
Q3 | $5.94M | Hold |
94,000
| – | – | 0.53% | 43 |
|
|
2020
Q2 | $7.23M | Buy |
94,000
+50,000
| +114% | +$3.83M | 0.67% | 37 |
|
|
2020
Q1 | $3.29M | Buy |
+44,000
| New | +$3.04M | 0.36% | 68 |
|
|
2018
Q2 | – | Sell |
-36,000
| Closed | -$2.71M | – | 202 |
|
|
2018
Q1 | $2.71M | Sell |
36,000
-8,000
| -18% | -$636K | 0.32% | 94 |
|
|
2017
Q4 | $3.15M | Hold |
44,000
| – | – | 0.36% | 82 |
|
|
2017
Q3 | $3.56M | Buy |
44,000
+8,000
| +22% | +$612K | 0.41% | 74 |
|
|
2017
Q2 | $2.55M | Buy |
36,000
+16,000
| +80% | +$1.06M | 0.47% | 59 |
|
|
2017
Q1 | $1.36M | Buy |
+20,000
| New | +$1.41M | 0.25% | 98 |
|
|
2016
Q2 | – | Sell |
-9,000
| Closed | -$827K | – | 218 |
|
|
2016
Q1 | $827K | Sell |
9,000
-7,000
| -44% | -$631K | 0.2% | 129 |
|
|
2015
Q4 | $1.62M | Hold |
16,000
| – | – | 0.38% | 79 |
|
|
2015
Q3 | $1.57M | Hold |
16,000
| – | – | 0.37% | 79 |
|
|
2015
Q2 | $1.87M | Buy |
16,000
+2,000
| +14% | +$219K | 0.42% | 66 |
|
|
2015
Q1 | $1.37M | Hold |
14,000
| – | – | 0.28% | 93 |
|
|
2014
Q4 | $1.32M | Hold |
14,000
| – | – | 0.26% | 106 |
|
|
2014
Q3 | $1.49M | Hold |
14,000
| – | – | 0.29% | 106 |
|
|
2014
Q2 | $1.16M | Buy |
+14,000
| New | +$1.09M | 0.23% | 130 |
|
Other funds holding GILD
VCM
VPM
Cornerstone Advisors's GILD Position: Q1 2026 in Review
Cornerstone Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 35,000 shares — an estimated $4.3M sold.
Cornerstone Advisors first reported a position in GILD in Q2 2014 and held it in 32 quarters. The position peaked at $13.7M in Q1 2023. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Cornerstone Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Cornerstone Advisors sold 35,000 Gilead Sciences shares in Q1 2026, an estimated $4.3M.
- Cornerstone Advisors first reported a position in Gilead Sciences in Q2 2014 and held it in 32 quarters.
- Cornerstone Advisors's Gilead Sciences position peaked at $13.7M in Q1 2023.
- 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Cornerstone Advisors's 13F filing for Q1 2026, filed 8 May 2026.